4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Intermediate High Bohloeki

Tlhaloso e Khutšoanyane:

4-[(4-Methylpiperazin-1-yl)methyl]benzoic Acid Dihydrochloride

CAS: 106261-49-8

Ponahalo: Bosoeu ho isa ho Phofo e Batlileng e Tšoeu ho Crystal

Bohloeki: ≥98.0% (HPLC)

Bohareng ba Imatinib Mesylate (CAS: 220127-57-1) ha ho phekoloa Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

Boleng bo Phahameng, Tlhahiso ea Khoebo

Inquiry: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale 4- [(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
Litlhaloso tse tšoanang Imatinib Mesylate ea Mahareng
Nomoro ea CAS 106261-49-8
Nomoro ea KAtse RF-PI229
Boemo ba Setoko Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule Setšoantšo sa C13H20Cl2N2O2
Boima ba Molek'hule 307.22
Melting Point 305.0~307.0℃
Solubility E qhibilihang ka Metsing
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Bosoeu ho isa ho Phofo e Batlileng e Tšoeu ho isa ho Crystal
Mokhoa oa Bohloeki / Analysis ≥98.0% (HPLC)
Tahlehelo ka ho Omisa ≤0.50%
Masalla ha a tuka ≤0.50%
Litšila ka Kakaretso ≤2.0%
Ho se hloeke ho hoholo ho le Mong ≤1.0%
Tekanyetso ea Teko Maemo a Khoebo
Tšebeliso Pharmaceutical Intermediate of Imatinib Mesylate (CAS: 220127-57-1)

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, Cardboard drum, 25kg/Drum, kapa ho latela tlhoko ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.

Melemo:

1

LBH:

Kopo:

Shanghai Ruifu Chemical Co., Ltd. ke moetsi ea ka sehloohong le mofani oa thepa ea 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) e nang le boleng bo phahameng.Eonake ea mahareng ka tloaelo ho motsoako oa Imatinib Mesylate (CAS: 220127-57-1).Imatinib Mesylate ke tyrosine kinase inhibitor, e khethehileng haholo bakeng sa BCR-ABL, setlhare sa molomo bakeng sa phekolo ea bakuli ba baholo ba nang le Philadelphia chromosome positive chronic myeloid leukemia (CML) in the acute phase le mefuta e meng ea acute lymphoblastic leukemia (ALL), e potlakile. mohato le mohato o sa foleng ka mor'a ho hlōleha ha phekolo ea interferon.

Ngola molaetsa wa hao mona mme o re romele wona